Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts)
QFRD213385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
129,544.00
Year-over-Year Change
20.35%
Date Range
10/1/2000 - 4/1/2025
Summary
This economic indicator tracks trade accounts and notes receivable for U.S. pharmaceutical corporations, providing insight into the financial health and credit dynamics of the pharmaceutical sector. It measures the value of outstanding receivables, which reflects companies' sales, credit terms, and potential cash flow risks.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the net receivables for pharmaceutical companies, indicating their sales performance and credit management strategies. Economists use this metric to assess sector liquidity, credit risk, and overall financial performance of pharmaceutical firms.
Methodology
Data is collected through quarterly financial reports submitted by pharmaceutical corporations, aggregated and processed by the U.S. Federal Reserve.
Historical Context
This indicator is used by financial analysts, investors, and policymakers to evaluate the economic performance and credit conditions in the pharmaceutical industry.
Key Facts
- Measures net trade accounts for U.S. pharmaceutical corporations
- Indicates sector financial health and credit management
- Provides insights into pharmaceutical company sales performance
FAQs
Q: What does this economic indicator measure?
A: It tracks trade accounts and notes receivable for U.S. pharmaceutical corporations, showing the value of outstanding sales credits.
Q: Why are pharmaceutical receivables important?
A: They provide insights into the financial health, sales performance, and credit management of pharmaceutical companies.
Q: How is this data collected?
A: The data is gathered from quarterly financial reports submitted by pharmaceutical corporations and processed by the U.S. Federal Reserve.
Q: How do investors use this information?
A: Investors analyze this trend to assess the financial stability and performance potential of pharmaceutical companies.
Q: How often is this data updated?
A: The data is typically updated quarterly, reflecting the most recent financial reporting period for pharmaceutical corporations.
Related Trends
Contributions to the Chicago Fed Midwest Economy Index: Michigan Contribution: Manufacturing Sector
MANUMIM683SFRBCHI
Quarterly Financial Report: U.S. Corporations: Management and Technical Consulting Services: Short-Term Debt, Original Maturity of 1 Year or Less: Other Short-Term Loans, Including Commercial Paper
QFRD304546USNO
Quarterly Financial Report: U.S. Corporations: Food and Beverage Stores: Income (Loss) from Operations
QFR104445USNO
Quarterly Financial Report: U.S. Corporations: Computer and Peripheral Equipment: Current Portion of Long-Term Debt, Due in 1 Year or Less: Loans from Banks
QFR310374USNO
Quarterly Financial Report: U.S. Corporations: Transportation Equipment: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301TRAUSNO
Quarterly Financial Report: U.S. Corporations: Beverage and Tobacco Products: All Other Operating Costs and Expenses
QFR103312USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Trade Accounts and Trade Notes Receivable (Less Allowance for Doubtful Accounts) [QFRD213385USNO], retrieved from FRED.
Last Checked: 8/1/2025